| Intestinal permeability and drug absorption: predictive experimental, computational and in vivo approaches D Dahlgren, H Lennernäs Pharmaceutics 11 (8), 411, 2019 | 216 | 2019 |
| Direct in vivo human intestinal permeability (Peff) determined with different clinical perfusion and intubation methods D Dahlgren, C Roos, E Sjögren, H Lennernäs Journal of pharmaceutical sciences 104 (9), 2702-2726, 2015 | 118 | 2015 |
| Chemotherapeutics-induced intestinal mucositis: pathophysiology and potential treatment strategies D Dahlgren, M Sjöblom, PM Hellström, H Lennernäs Frontiers in pharmacology 12, 681417, 2021 | 110 | 2021 |
| Regional intestinal permeability of three model drugs in human D Dahlgren, C Roos, A Lundqvist, B Abrahamsson, C Tannergren, ... Molecular pharmaceutics 13 (9), 3013-3021, 2016 | 64 | 2016 |
| Human in Vivo Regional Intestinal Permeability: Quantitation Using Site-Specific Drug Absorption Data E Sjogren, D Dahlgren, C Roos, H Lennernas Molecular pharmaceutics 12 (6), 2026-2039, 2015 | 59 | 2015 |
| Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability D Dahlgren, M Venczel, JP Ridoux, C Skjöld, A Müllertz, R Holm, ... European journal of pharmaceutics and biopharmaceutics 163, 240-251, 2021 | 58 | 2021 |
| In Vivo Mechanisms of Intestinal Drug Absorption from Aprepitant Nanoformulations C Roos, D Dahlgren, S Berg, J Westergren, B Abrahamsson, ... Molecular Pharmaceutics 14 (12), 4233-4242, 2017 | 57 | 2017 |
| Regional intestinal permeability in rats: a comparison of methods C Roos, D Dahlgren, E Sjögren, C Tannergren, B Abrahamsson, ... Molecular pharmaceutics 14 (12), 4252-4261, 2017 | 47 | 2017 |
| The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs D Dahlgren, C Roos, P Johansson, C Tannergren, A Lundqvist, ... International journal of pharmaceutics, 2018 | 46 | 2018 |
| Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker 51Cr-EDTA D Dahlgren, C Roos, A Lundqvist, C Tannergren, P Langguth, ... Molecular pharmaceutics 14 (12), 4243-4251, 2017 | 38 | 2017 |
| Regional intestinal permeability in dogs: Biopharmaceutical aspects for development of oral modified-release dosage forms D Dahlgren, C Roos, P Johansson, A Lundqvist, C Tannergren, ... Molecular Pharmaceutics 13 (9), 3022-3033, 2016 | 37 | 2016 |
| Intestinal absorption-modifying excipients: A current update on preclinical in vivo evaluations D Dahlgren, M Sjöblom, H Lennernäs European Journal of Pharmaceutics and Biopharmaceutics 142, 411-420, 2019 | 35 | 2019 |
| Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport D Dahlgren, C Roos, A Lundqvist, C Tannergren, M Sjöblom, E Sjögren, ... International journal of pharmaceutics 549 (1-2), 239-248, 2018 | 32 | 2018 |
| Antibody-drug conjugates and targeted treatment strategies for hepatocellular carcinoma: a drug-delivery perspective D Dahlgren, H Lennernäs Molecules 25 (12), 2861, 2020 | 28 | 2020 |
| Jejunal absorption of aprepitant from nanosuspensions: Role of particle size, prandial state and mucus layer C Roos, D Dahlgren, E Sjögren, M Sjöblom, M Hedeland, H Lennernäs European journal of pharmaceutics and biopharmaceutics 132, 222-230, 2018 | 27 | 2018 |
| Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model D Dahlgren, C Roos, K Peters, A Lundqvist, C Tannergren, E Sjögren, ... European Journal of Pharmaceutics and Biopharmaceutics 142, 31-37, 2019 | 26 | 2019 |
| Mechanistic modelling of intestinal drug absorption–The in vivo effects of nanoparticles, hydrodynamics, and colloidal structures C Roos, J Westergren, D Dahlgren, H Lennernäs, E Sjögren European Journal of Pharmaceutics and Biopharmaceutics 133, 70-76, 2018 | 26 | 2018 |
| Time-dependent effects on small intestinal transport by absorption-modifying excipients D Dahlgren, C Roos, A Lundqvist, C Tannergren, M Sjöblom, E Sjögren, ... European Journal of Pharmaceutics and Biopharmaceutics 132, 19-28, 2018 | 23 | 2018 |
| Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats D Dahlgren, T Olander, M Sjöblom, M Hedeland, H Lennernäs Acta Pharmaceutica Sinica B 11 (6), 1667-1675, 2021 | 21 | 2021 |
| The in vivo effect of transcellular permeation enhancers on the intestinal permeability of two peptide drugs enalaprilat and hexarelin D Dahlgren, M Sjöblom, M Hedeland, H Lennernäs Pharmaceutics 12 (2), 99, 2020 | 18 | 2020 |
